Bellevue Group’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,290
| Closed | -$426K | – | 149 |
|
|
2025
Q1 | $426K | Sell |
11,290
-748
| -6% | -$28.2K | 0.01% | 121 |
|
|
2024
Q4 | $985K | Buy |
12,038
+57
| +0.5% | +$4.67K | 0.02% | 115 |
|
|
2024
Q3 | $1.37M | Sell |
11,981
-2,229
| -16% | -$255K | 0.02% | 112 |
|
|
2024
Q2 | $1.07M | Buy |
14,210
+966
| +7% | +$72.9K | 0.02% | 121 |
|
|
2024
Q1 | $905K | Sell |
13,244
-2,556
| -16% | -$175K | 0.01% | 123 |
|
|
2023
Q4 | $992K | Sell |
15,800
-14,700
| -48% | -$923K | 0.02% | 123 |
|
|
2023
Q3 | $1.55M | Buy |
30,500
+4,500
| +17% | +$229K | 0.03% | 116 |
|
|
2023
Q2 | $1.3M | Buy |
+26,000
| New | +$1.3M | 0.02% | 121 |
|